BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9306332)

  • 1. 5-Aminosalicylic acid (5-ASA) and chronic tubulointerstitial nephritis in patients with chronic inflammatory bowel disease: is there a link?
    De Broe ME; Stolear JC; Nouwen EJ; Elseviers MM
    Nephrol Dial Transplant; 1997 Sep; 12(9):1839-41. PubMed ID: 9306332
    [No Abstract]   [Full Text] [Related]  

  • 2. Review article: interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease.
    Corrigan G; Stevens PE
    Aliment Pharmacol Ther; 2000 Jan; 14(1):1-6. PubMed ID: 10632639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapsing tubulointerstitial nephritis in an adolescent with inflammatory bowel disease without aminosalicylate exposure.
    Shahrani Muhammad HS; Peters C; Casserly LF; Dorman AM; Watts M
    Clin Nephrol; 2010 Mar; 73(3):250-2. PubMed ID: 20178728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesalazine-associated acute tubulointerstitial nephritis in a patient with spondylarthropathy.
    Sari I; Birlik M; Cavdar C; Sarioglu S; Akpinar H; Onen F; Akkoc N
    N Z Med J; 2005 Sep; 118(1222):U1662. PubMed ID: 16222356
    [No Abstract]   [Full Text] [Related]  

  • 5. 5-ASA therapy and renal function in inflammatory bowel disease.
    Siveke JT; Egert J; Sitter T; Schiemann U; Walcher P; Török HP; Glas J; Folwaczny C
    Am J Gastroenterol; 2005 Feb; 100(2):501. PubMed ID: 15667517
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic interstitial nephritis due to 5-aminosalicylic acid.
    Agharazii M; Marcotte J; Boucher D; Noël R; Lebel M
    Am J Nephrol; 1999; 19(3):373-6. PubMed ID: 10393373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association of Mesalamine With Kidney Disease.
    Adiga A; Goldfarb DS
    Adv Chronic Kidney Dis; 2020 Jan; 27(1):72-76. PubMed ID: 32147005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute interstitial nephritis associated with the use of mesalazine in inflammatory bowel disease.
    Frandsen NE; Saugmann S; Marcussen N
    Nephron; 2002 Sep; 92(1):200-2. PubMed ID: 12187103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic interstitial nephritis induced by 5-aminosalicylic acid: a new case report].
    Laboudi A; Makdassi R; Cordonnier C; Fournier A; Choukroun G
    Nephrologie; 2002; 23(7):343-7. PubMed ID: 12500420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Severe tubulo-interstitial nephritis secondary to 5-ASA].
    Bosque López MJ; Garrido Durán C; Ginard Vicens D; Munar Vila MA; Vanrell Garau M; Mariño Méndez Z; Gayà Cantallops J
    Gastroenterol Hepatol; 2009 Jan; 32(1):29-31. PubMed ID: 19174096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How safe are the safest IBD drugs?
    Lewis JD
    Gastroenterology; 2003 Jun; 124(7):1986-7; discussion 1987-8. PubMed ID: 12806636
    [No Abstract]   [Full Text] [Related]  

  • 12. Interstitial nephritis in children with Crohn's disease.
    Benador N; Grimm P; Lemire J; Griswold W; Billman G; Reznik V
    Clin Pediatr (Phila); 2000 Apr; 39(4):253-4. PubMed ID: 10791141
    [No Abstract]   [Full Text] [Related]  

  • 13. [Interstitial nephritis associated with mesalazine therapy].
    Vuotila M; Ikäheimo R; Pietiläinen T
    Duodecim; 2003; 119(20):1978-82. PubMed ID: 14640003
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute renal failure in a 53-year-old woman with Crohn's disease treated with 5-aminosalicylic acid.
    Haas M; Shetye KR
    Am J Kidney Dis; 2001 Jul; 38(1):205-9. PubMed ID: 11431204
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute tubular injury associated with mesalazine therapy in an adolescent girl with inflammatory bowel disease.
    Uslu N; Demir H; Saltik-Temizel IN; Topaloğlu R; Gürakan F; Yüce A
    Dig Dis Sci; 2007 Nov; 52(11):2926-9. PubMed ID: 17404867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal effects of long-term treatment with 5-aminosalicylic acid.
    Patel H; Barr A; Jeejeebhoy KN
    Can J Gastroenterol; 2009 Mar; 23(3):170-6. PubMed ID: 19319380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Look out for toxic effects of mesalamines!
    Goldstein F
    J Clin Gastroenterol; 2001 Feb; 32(2):98. PubMed ID: 11205663
    [No Abstract]   [Full Text] [Related]  

  • 18. Mesalazine-induced interstitial nephritis in a patient with ulcerative colitis.
    Gorospe EC; Leggett CL
    BMJ Case Rep; 2012 Feb; 2012():. PubMed ID: 22665567
    [No Abstract]   [Full Text] [Related]  

  • 19. 5-aminosalicylic acids and the risk of renal disease: a large British epidemiologic study.
    Van Staa TP; Travis S; Leufkens HG; Logan RF
    Gastroenterology; 2004 Jun; 126(7):1733-9. PubMed ID: 15188168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesalazine-associated tubulo-interstitial nephritis in inflammatory bowel disease.
    Calviño J; Romero R; Pintos E; Losada E; Novoa D; Güimil D; Mardaras J; Sanchez-Guisande D
    Clin Nephrol; 1998 Apr; 49(4):265-7. PubMed ID: 9582560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.